Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Wednesday 04 December, 2019

Benchmark Hlgs PLC

Directorate Change

RNS Number : 5458V
Benchmark Holdings PLC
04 December 2019

4 December 2019


Benchmark Holdings plc


("Benchmark" or the "Company")


Directorate Change


Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, provides an update on the Directorate Change announcement issued on 19 August 2019 regarding Malcolm Pye stepping down as Benchmark's Chief Executive Officer and becoming a non-executive director of the Company.


Having completed a successful handover of his executive responsibilities over the last three months, Malcolm Pye has notified the Company that he has decided to retire from the board with effect from today in order to pursue other opportunities. The Board of Benchmark reiterates its thanks to Malcolm for his considerable contribution during his time with the Group.




Benchmark Holdings plc

                      Tel: 020 3696 0630

Peter George, Executive Chairman

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

                      Tel: 020 7260 1000

James Black / Freddie Barnfield / Duncan Monteith


Tel: 020 3128 8742                           

Katie Hunt / Reg Hoare / Alistair de Kare-Silver     

[email protected]


Notes to Editors:

Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments. Find out more at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t